Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01998100 · ClinicalTrials.gov registry record · Phase 3
Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)
A Phase 3 study of Post Traumatic Stress Disorder, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 3
- Development phase
- 28
- Enrollment target
- 2
- Study locations
NCT01998100: Completed Phase 3 study of Post Traumatic Stress Disorder, sponsored by University of Texas at Austin.
NCT01998100 is a Phase 3 study of Post Traumatic Stress Disorder that has completed, run by University of Texas at Austin. The registered enrollment target is 28 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01998100, a Phase 3 study of Post Traumatic Stress Disorder, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 28 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exercise + therapy and therapy alone condition) will be compared in terms of levels of brain-derived neurotrophic factor (BDNF). BDNF is a protein that helps to support the survival of existing neurons and stimulate the growth of new neurons and synapses. BDNF is important to learning and memory in general and therefore may be associated with the learning and memory as it relates to PE and corresponding symptoms PTSD improvement.
Primary Outcome
Self-report measure that assesses PTSD symptoms. Will be assessed at each visit throughout the three month protocol.
Conditions Studied
Interventions
- BEHAVIORAL Exercise
- BEHAVIORAL Prolonged Exposure
Study Locations (2)
Texas
- The University of Texas at Austin - Austin
- Southern Methodist University - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-09 |
| Est. Completion | 2013-07 |
| Phase | Phase 3 |
What the finished NCT01998100 record still lists
NCT01998100 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Exercise is the first listed.
NCT01998100 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01998100 about?
NCT01998100 is a clinical study titled "Maximizing Treatment Outcome in Post-Traumatic Stress Disorder (PTSD)". The purpose of this study is to examine the efficacy of exercise + therapy to therapy alone to determine if they can improve the effects of prolonged exposure therapy (PE) in reducing symptoms of anxiety associated with Post-traumatic Stress Disorder (PTSD). In addition the two strategies (i.e., exe...
What is the current status of trial NCT01998100?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 28 participants. The study started on 2010-09. Estimated completion is 2013-07.
What conditions does trial NCT01998100 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT01998100?
The interventions under investigation include: Exercise (BEHAVIORAL), Prolonged Exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT01998100?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01998100 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01998100's enrollment target sits among peer trials
28 220th of 262 higher than 42 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
RECRUITING · Phase 3
-
Goal-Directed Sedation in Mechanically Ventilated Infants and Children
RECRUITING · Phase 3
-
MDMA-assisted Massed Prolonged Exposure for PTSD
RECRUITING · Phase 3
-
Repurposing Low-Dose Clonidine for PTSD in Veterans
RECRUITING · Phase 3
-
Predicting Responses to PTSD Treatment With Iris and Cardiovascular Tests
ACTIVE NOT RECRUITING · Phase 3
-
Frontline Clinician Psilocybin Study
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia